Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors (Q37412304)
Jump to navigation
Jump to search
scientific article published on 14 September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors |
scientific article published on 14 September 2009 |
Statements
1 reference
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors (English)
1 reference
Pravin T P Kaumaya
1 reference
Kevin Chu Foy
1 reference
Joan Garrett
1 reference
Sharad V Rawale
1 reference
Daniele Vicari
1 reference
Jennifer M Thurmond
1 reference
Tammy Lamb
1 reference
Aruna Mani
1 reference
Yahaira Kane
1 reference
Catherine R Balint
1 reference
Donald Chalupa
1 reference
Gregory A Otterson
1 reference
Charles L Shapiro
1 reference
Jeffrey M Fowler
1 reference
Michael R Grever
1 reference
Tanios S Bekaii-Saab
1 reference
William E Carson
1 reference
14 September 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference